Last reviewed · How we verify
Adenosylcobalamin
At a glance
| Generic name | Adenosylcobalamin |
|---|---|
| Also known as | Cobazim 3000 |
| Sponsor | Fakultas Kedokteran Universitas Indonesia |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | Phase 1 |
Approved indications
- Prevention of Vitamin B12 Deficiency
Common side effects
Key clinical trials
- Evaluation of a Genetically Determined Personalized Approach in Prescribing Biologically Active Substances in Patients With Elevated Blood Homocysteine Levels. (NA)
- Phase 2 Study of HL-009 Liposomal Gel to Treat Mild to Moderate Atopic Dermatitis (PHASE2)
- The Role of Cobamamide Supplements in Malnourished Patients (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Adenosylcobalamin CI brief — competitive landscape report
- Adenosylcobalamin updates RSS · CI watch RSS
- Fakultas Kedokteran Universitas Indonesia portfolio CI